Navaya Inc., an innovative cannabis producer based near Laval in Boisbriand, has received its sales licence from Health Canada to sell dried cannabis products across Canada. The licence brings to fruition the goal set out by Navaya to deliver high yield, consistent quality cannabis, to all Canadians of legal age. The newly licensed producer will be launching its products at Société québécoise du cannabis (SQDC) locations across the province of Quebec.

“After two years of hard work and labour, we’ve achieved our goal of acquiring our sales licence to sell dried cannabis products” says Sophie Denis, director of operations at Navaya.

Will Omicron lead to a rise in sales at cannabis shops in Kanesatake?

It might be too early too early to tell, said Green Devil dispensary owner Clifton Nicholas.

“I don’t know whether we’ve seen a big difference in numbers yet but I’ve definitely received more phone calls from people asking what our protocols are,” said the store owner.

As of Tuesday, January 18, customers wishing to purchase cannabis in person at the SQDC (Société québécoise du cannabis) have been required to show a proof of vaccination recognizing that they are adequately protected. The same protocol has also been applied across SAQ liquor stores (Société des alcools du Québec).

Proof of vaccination is now required to enter SAQ liquor stores (Société des alcools du Québec) and SQDC pot shops (Société québécoise du cannabis) in the province.

SiliCycle Inc., a company working in the health field, founded and established in Quebec, takes a major step allowing it to directly reach medical customers. The company has obtained approval to sell directly to consumers with a prescription for medical cannabis. It is through its subsidiary PurCann Pharma and under the OOVIE ™ medical brand that the first products will be available on the Quebec and Canadian markets in the coming weeks.

Nicholas Sosiak, CFO of Cannara Biotech Inc., discusses the accelerated retail price compression of cannabis products

Price skimming is a common pricing strategy that companies use to maximize profits by initially charging the highest possible price in any new industry and gradually discounting prices over time to address a broader and more price sensitive segment of the market.

Three years into cannabis legalization, we’re now seeing an accelerated retail price compression, which is favourable for the consumers but not all producers are prepared to support this downward price trend.

In Quebec, the most commonly sold product is the 3.5 gram dried flower, which accounts for the majority of all dried flower sales.

Quebec officials have reported the number of first-dose appointments for Covid-19 vaccines have quadrupled after announcing that vaccination passports will be required to enter liquor and cannabis stores. 

When the munchies lead to blood, grit and death

The Quebec government may soon require people to show proof of COVID-19 vaccination before buying alcohol at the Société des alcools du Québec (SAQ) or cannabis products at the Société québécoise du cannabis (SQDC).

"If the government goes in this direction, we will apply this sanitary measure -- as we have done with all other efforts deployed since the beginning of the pandemic," said SAQ spokesperson Yann Langlais Plante.

Organigram Holdings Inc. OGI, 0.00% OGI, -0.44% said Tuesday it acquired all of the issued and outstanding shares of Laurentian Organic Inc. for about $28 million plus additional earnout considerations based on 2022 and 2023 Ebitda benchmarks. The Laurentian acquisition will allow Organigram to reach into premium products, including hash and craft cannabis, and grow its footprint in Quebec, the company said. Shares of Organigram rose 1% in premarket trades.

HEXO Corp (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”), a leading producer of high-quality cannabis products, today reported its financial results for the fiscal quarter ended October 31, 2021 (Q1’22), and announced “The Path Forward”, a new strategic plan to solidify itself as Canada’s leading cannabis company and position it to capitalize on international opportunities. The plan utilizes HEXO’s current assets, including its recent acquisitions and unique capabilities to drive accelerated growth and become cash flow positive within the next four quarters. This plan is underpinned by actions to strengthen its balance sheet, its executive team and its corporate governance.

Q1 2022 Highlights